JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.16% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Travere Therapeutics
TVTX
$5.79B
| $25.5M | ﹤0.01% |
1,134,151
-88,807
| -7% | -$1.89M |
|
1452
Stanley Black & Decker
SWK
$15.5B
| $25.4M | ﹤0.01% |
315,752
-340,425
| -52% | -$28.7M |
|
1453
Kulicke & Soffa
KLIC
$5.01B
| $25.4M | ﹤0.01% |
482,645
+167,669
| +53% | +$8.72M |
|
1454
Prosperity Bancshares
PB
$8.95B
| $25.4M | ﹤0.01% |
413,296
+122,378
| +42% | +$8.71M |
|
1455
CALL
Expedia Group
EXPE
$39.1B
| $25.4M | ﹤0.01% |
262,000
+119,200
| +83% | +$12.5M |
|
1456
iShares MSCI USA Value Factor ETF
VLUE
$9.72B
| $25.4M | ﹤0.01% |
274,334
-210,834
| -43% | -$19.8M |
|
1457
WisdomTree US LargeCap Dividend Fund
DLN
$6.45B
| $25.4M | ﹤0.01% |
410,576
+193,335
| +89% | +$12M |
|
|
TGNA
1458
DELISTED
TEGNA Inc
TGNA
| $25.3M | ﹤0.01% |
1,498,594
+573,807
| +62% | +$10.7M |
|
1459
ICL Group
ICL
$7.06B
| $25.3M | ﹤0.01% |
3,724,591
+975,801
| +35% | +$7.2M |
|
1460
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
| $25.3M | ﹤0.01% |
472,938
-4,093,467
| -90% | -$217M |
|
1461
Sabra Healthcare REIT
SBRA
$5.15B
| $25.3M | ﹤0.01% |
2,196,922
+148,480
| +7% | +$1.84M |
|
1462
American States Water
AWR
$3.49B
| $25.1M | ﹤0.01% |
282,325
+42,222
| +18% | +$3.86M |
|
1463
Qualys
QLYS
$6.47B
| $25.1M | ﹤0.01% |
192,915
+12,077
| +7% | +$1.42M |
|
1464
iShares US Healthcare ETF
IYH
$3.77B
| $25M | ﹤0.01% |
458,605
+29,495
| +7% | +$1.62M |
|
|
NOVA
1465
DELISTED
Sunnova Energy
NOVA
| $25M | ﹤0.01% |
1,603,089
+1,069,764
| +201% | +$18.7M |
|
1466
Intellia Therapeutics
NTLA
$1.66B
| $25M | ﹤0.01% |
671,132
+8,515
| +1% | +$334K |
|
1467
Vanguard Long-Term Treasury ETF
VGLT
$10.4B
| $25M | ﹤0.01% |
381,656
+191,400
| +101% | +$12.3M |
|
1468
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.92B
| $24.9M | ﹤0.01% |
190,935
+132,774
| +228% | +$15.9M |
|
1469
iShares MSCI Chile ETF
ECH
$1.03B
| $24.9M | ﹤0.01% |
865,450
+292,874
| +51% | +$8.28M |
|
1470
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $24.9M | ﹤0.01% |
127,716
-242
| -0.2% | -$46.3K |
|
1471
Allogene Therapeutics
ALLO
$683M
| $24.8M | ﹤0.01% |
5,024,544
+1,254,261
| +33% | +$8.04M |
|
1472
Unum
UNM
$14.5B
| $24.8M | ﹤0.01% |
626,272
+95,426
| +18% | +$3.94M |
|
1473
Trimble
TRMB
$13.4B
| $24.8M | ﹤0.01% |
472,156
+60,035
| +15% | +$3.2M |
|
1474
Gerdau
GGB
$9.48B
| $24.6M | ﹤0.01% |
5,991,626
+329,046
| +6% | +$1.47M |
|
1475
Olin
OLN
$2.13B
| $24.6M | ﹤0.01% |
443,317
-45,931
| -9% | -$2.63M |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,315 increased, 2,057 reduced and 651 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 651 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.